Released: 01/03/2010
01 March 2010, London, UK, and Cambridge, MA: Antisoma plc(LSE: ASM; USOTC: ATSMY) notifies the market that the Company's issued share capital consists of 626,502,510 ordinary shares with voting rights. Antisoma does not hold any ordinary shares in Treasury. Therefore, the total number of voting rights in Antisoma is 626,502,510. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Antisoma under the FSA's Disclosure and Transparency Rules. Enquiries: Daniel Elger VP, Marketing & Communications Antisoma plc +44 (0)20 3249 2100 Background on Antisoma Antisoma is a London Stock Exchange-listed biopharmaceutical company that develops novel products for the treatment of cancer. The Company has operations in the UK and the US. Please visit www.antisoma.com http://www.antisoma.com/ for further information about Antisoma. HUG#1389511